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Taking Malawi’s option B+ programme from a B+ to an A+
In The Lancet HIV, Beth A Tippett Barr and colleagues1 
present national estimates of early mother-to-child 
transmission (MTCT) of HIV and factors associated with 
early MTCT from the National Evaluation of Malawi’s 
Prevention of MTCT Program (NEMAPP) for the period 
2014–16. Among HIV-exposed infants aged 4–12 weeks, 
the MTCT rate was 3·7% (95% CI 2·3–6·0) and consistent 
across all four subnational regions. A somewhat lower 
prevalence was observed among infants aged 4–7 weeks 
than among those aged 8–12 weeks (2·9% vs 5·2%; 
p=0·07). As expected, the mother’s antiretroviral 
therapy (ART) status during pregnancy was strongly 
associated with MTCT prevalence: it was 2·3% 
(95% CI 1·3–4·0) among those who were on ART during 
pregnancy compared with 19·6% (14·3–26·3) among 
those who were not on ART (p<0·0001).
Malawi pioneered its prevention of MTCT option B+ 
programme in late 2011 in response to the poor results 
of a CD4-based programme that was hindered by 
delays in ART access.2 Option B+ was designed for 
simplicity and impact, offering all pregnant and 
breastfeeding women free lifelong ART at diagnosis, 
regardless of CD4 count or clinical stage. Although 
no nationally representative estimates of early MTCT 
were available before the introduction of option B+, 
comparable estimates from immunisation settings were 
considerably higher and varied by region.3 Thus, this 
nationally representative study suggests a substantial 
decline in the prevalence of early MTCT 3–5 years after 
option B+ was introduced.
NEMAPP has several important strengths. First, it is 
national in scope and uses a rigorous sampling method 
to obtain nationally and subnationally representative 
estimates. Second, mothers were recruited in under-5 
vaccination and outpatient sick-child clinics, which are 
settings with near universal attendance in Malawi.4 
Third, the authors assessed actual infant HIV infection, 
and not an intermediate maternal outcome or proxy. 
Together, these strengths resulted in the first national 
estimates of early MTCT under option B+. 
Although NEMAPP provides better estimates of early 
MTCT than do routine programme data, missing data 
are the study’s weakness. Non-participants include 
mothers who declined participation, were too sick to 
present, or were not engaged in the health-care system, 
as well as infants who died before clinic attendance. 
Although these groups might be small, they are all at 
higher risk of early MTCT than those who participated, 
suggesting that a transmission rate of 3·7% might be an 
underestimate. 
Tippett Barr and colleagues’ study highlights 
three sets of challenges that need to be addressed to 
further reduce the prevalence of early MTCT. First, of the 
99 MTCT cases observed in the raw data, 52 occurred in 
infants whose mothers were on ART during pregnancy, 
suggesting challenges associated with maternal ART 
retention and adherence. Several barriers related to the 
mothers, their partners, and their communities and 
environments might contribute to these behaviours, 
and several promising evidence-based interventions are 
available to address them.5–8 
Second, there are challenges associated with maternal 
HIV acquisition during pregnancy and breastfeeding. 
High rates of early MTCT were observed among infants 
whose mothers’ self-reported HIV status during 
pregnancy was negative (weighted proportion 20·9%, 
95% CI 12·0–33·8), suggesting that some mothers 
are being infected during the peripartum period. 
Several prevention approaches exist for reducing 
HIV acquisition among pregnant and breastfeeding 
women, including pre-exposure prophylaxis,9 repeat 
couple testing to identify HIV-discordant couples,10 
and testing and treating HIV-infected men in the 
general population to reduce ongoing heterosexual 
transmission.11
Third, there are challenges in identifying HIV-exposed 
infants and engaging them in care. Less than half 
of HIV-exposed infants in the analysis were enrolled 
in an exposed infant care clinic at the time of study 
screening, despite presenting to a health facility. This 
finding underscores the need to strengthen the infant 
steps of the prevention of MTCT cascade. Integration 
of routine maternal retesting and point-of-care, early 
infant diagnosis procedures into immunisation clinics 
are promising steps for rapidly identifying those in 
need of services.12,13 Similar improvements in Malawi’s 
antenatal programme, including integration of routine 
maternal testing and elimination of laboratory delays, 
have been integral to the success of option B+ along the 
early steps of the prevention of MTCT cascade. 
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This study shows that the prevalence of early vertical 
transmission under Malawi’s option B+ programme was 
low only a few years after it was introduced. To achieve 
further declines, attention needs to be paid to HIV-
infected women who experience challenges along the 
ART cascade, uninfected women who are at the highest 
risk of HIV acquisition, and HIV-exposed infants in need 
of care. These steps are important for Malawi and other 
high-prevalence settings that have followed Malawi’s 
lead in adopting option B+. 
*Nora E Rosenberg, Audrey E Pettifor 
Department of Health Behavior (NER) and Department of 
Epidemiology (AEP), University of North Carolina at Chapel Hill, 
Chapel Hill, NC 27599-7440, USA; and University of North 
Carolina Project–Malawi, Lilongwe, Malawi (NER) 
ora_rosenberg@unc.edu
NER is supported, in part, by the National Institute of Health through grants 
R00 MH104154 and P30 AI50410. The funder had no part in the writing of this 
manuscript or in the decision to submit for publication. We declare no 
competing interests. 
1 Tippett Barr BA, van Lettow M, van Oosterhout JJ, et al. National estimates 
and risk factors associated with early mother-to-child transmission of HIV 
after implementation of option B+: a cross-sectional analysis. Lancet HIV 
2018; published online Nov 19. http://dx.doi.org/10.1016/S2352-
3018(18)30316-3.
2 Schouten EJ, Jahn A, Midiani D, et al. Prevention of mother-to-child 
transmission of HIV and the health-related Millennium Development 
Goals: time for a public health approach. Lancet 2011; 378: 282–84.
3 Sinunu MA, Schouten EJ, Wadonda-Kabondo N, et al. Evaluating the impact 
of prevention of mother-to-child transmission of HIV in Malawi through 
immunization clinic-based surveillance. PLoS One 2014; 9: e100741.
4 National Statistical Office, The DHS Program. Malawi Demographic and 
Health Survey 2015–16. 2017. https://dhsprogram.com/pubs/pdf/FR319/
FR319.pdf (accessed Nov 14, 2018).
5 McCoy SI, Njau PF, Fahey C, et al. Cash vs food assistance to improve 
adherence to antiretroviral therapy among HIV-infected adults in Tanzania. 
AIDS 2017; 31: 815–25.
6 Phiri S, Tweya H, van Lettow M, et al. Impact of facility- and community-based 
peer support models on maternal uptake and retention in Malawi’s option B+ 
HIV prevention of mother-to-child transmission program: a 3-arm cluster 
randomized controlled trial (PURE Malawi). J Acquir Immune Defic Syndr 2017; 
75 (suppl 2): S140–48.
7 Aliyu MH, Blevins M, Audet CM, et al. Integrated prevention of 
mother-to-child HIV transmission services, antiretroviral therapy initiation, 
and maternal and infant retention in care in rural north-central Nigeria: 
a cluster-randomised controlled trial. Lancet HIV 2016; 3: e202–11.
8 Audet CM, Blevins M, Chire YM, et al. Engagement of men in antenatal 
care services: increased HIV testing and treatment uptake in a community 
participatory action program in Mozambique. AIDS Behav 2016; 
20: 2090–100.
9 Joseph Davey DL, Bekker LG, Gorbach PM, Coates TJ, Myer L. 
Delivering preexposure prophylaxis to pregnant and breastfeeding 
women in sub-Saharan Africa: the implementation science frontier. AIDS 
2017; 31: 2193–97.
10 Rosenberg NE, Hauser BM, Ryan J, Miller WC. The effect of HIV counselling 
and testing on HIV acquisition in sub-Saharan Africa: a systematic review. 
Sex Transm Infect 2016; 92: 579–86.
11 Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV 
testing with immediate antiretroviral therapy as a strategy for elimination of 
HIV transmission: a mathematical model. Lancet 2009; 373: 48–57.
12 Chi BH, Bolton-Moore C, Holmes CB. Prevention of mother-to-child HIV 
transmission within the continuum of maternal, newborn, and child health 
services. Curr Opin HIV AIDS 2013; 8: 498–503.
13 Mwenda R, Fong Y, Magombo T, et al. Significant patient impact observed 
upon implementation of point-of-care early infant diagnosis technologies 
in an observational study in Malawi. Clin Infect Dis 2018; 67: 701–07.
